1887

Abstract

Daptomycin is licensed for the management of infections in adults, including those caused by meticillin-resistant (MRSA). Few data exist on paediatric use or dose guidance in neonates. We report the case of a neonate with MRSA bacteraemia successfully managed with daptomycin. Dose requirements were substantially higher than those recommended for adults.

Keyword(s): i.v., intravenous
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.027235-0
2011-03-01
2019-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/3/381.html?itemId=/content/journal/jmm/10.1099/jmm.0.027235-0&mimeType=html&fmt=ahah

References

  1. Abdel-Rahman, S. M., Benziger, D. P., Jacobs, R. F., Jafri, H. S., Hong, E. F. & Kearns, G. L. ( 2008; ). Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections. Pediatr Infect Dis J 27, 330–334.[CrossRef]
    [Google Scholar]
  2. Carey, A. J. & Long, S. S. ( 2010; ). Staphylococcus aureus: a continuously evolving and formidable pathogen in the neonatal intensive care unit. Clin Perinatol 37, 535–546.[CrossRef]
    [Google Scholar]
  3. Cohen-Wolkowiez, M., Smith, P. B., Benjamin, D. K., Jr, Fowler, V. G., Jr & Wade, K. C. ( 2008; ). Daptomycin use in infants: report of two cases with peak and trough drug concentrations. J Perinatol 28, 233–234.[CrossRef]
    [Google Scholar]
  4. Dvorchik, B. H., Brazier, D., DeBruin, M. F. & Arbeit, R. D. ( 2003; ). Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother 47, 1318–1323.[CrossRef]
    [Google Scholar]
  5. Hawkey, P. M. ( 2008; ). Pre-clinical experience with daptomycin. J Antimicrob Chemother 62 (Suppl. 3), iii7–iii14.
    [Google Scholar]
  6. Johnson, A. P., Sharland, M., Goodall, C. M., Blackburn, R., Kearns, A. M., Gilbert, R., Lamagni, T. L., Charlett, A., Ganner, M. & other authors ( 2010; ). Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland. Arch Dis Child 95, 781–785.[CrossRef]
    [Google Scholar]
  7. Kanafani, Z. A. & Corey, G. R. ( 2007; ). Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections. Expert Rev Anti Infect Ther 5, 177–184.[CrossRef]
    [Google Scholar]
  8. Lodise, T. P., Graves, J., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B. M. & Stellrecht, K. ( 2008; ). Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 52, 3315–3320.[CrossRef]
    [Google Scholar]
  9. Moise, P. A., Sakoulas, G., Forrest, A. & Schentag, J. J. ( 2007; ). Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteraemia. Antimicrob Agents Chemother 51, 2582–2586.[CrossRef]
    [Google Scholar]
  10. Tobin, C. M., Darville, J. M., Lovering, A. M. & Macgowan, A. P. ( 2008; ). An HPLC assay for daptomycin in serum. J Antimicrob Chemother 62, 1462–1463.[CrossRef]
    [Google Scholar]
  11. Yoon, Y. K., Kim, J. Y., Park, D. W., Sohn, J. W. & Kim, M. J. ( 2010; ). Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. J Antimicrob Chemother 65, 1015–1018.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.027235-0
Loading
/content/journal/jmm/10.1099/jmm.0.027235-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error